NDC directory

ENZEEVU

aflibercept · Sandoz Inc · INJECTION, SOLUTION

61314-504BLAVascular Endothelial Growth Factor Inhibitor [EPC]
Product NDC
61314-504
Generic name
aflibercept
Labeler name
Sandoz Inc
Brand name
ENZEEVU
Finished
true
Listing expiration date
20271231
Marketing category
BLA
Dosage form
INJECTION, SOLUTION
SPL ID
6f1d28a8-1c10-40d2-83f0-6a528f807b92
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261026
Product ID
61314-504_6f1d28a8-1c10-40d2-83f0-6a528f807b92
Application number
BLA761382
Brand name base
ENZEEVU
Active ingredients
  1. Name
    AFLIBERCEPT
    Strength
    2 mg/.05mL
Packaging
  1. Package NDC
    61314-504-63
    Description
    1 SYRINGE, GLASS in 1 CARTON (61314-504-63) / .05 mL in 1 SYRINGE, GLASS
    Marketing start date
    20261026
    Sample
    false
Route
INTRAVITREAL
Pharm class
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.